A phase 1 study of neoadjuvant chemotherapy followed by concurrent chemoradiation with gemcitabine, sorafenib, and vorinostat in pancreatic cancer.

被引：6
|
作者：
Poklepovic, Andrew Stewart [1 ]
Fields, Emma Charlotte [1 ]
Bandyopadhyay, Dipankar [1 ]
Tombes, Mary Beth [1 ]
Kmieciak, Maciej [1 ]
McGuire, William P. [1 ]
Gordon, Sarah W. [1 ]
Kaplan, Brian J. [1 ]
Myers, Jennifer Lynn [1 ]
Matin, Khalid [1 ]
Patel, Bhaumik [1 ]
Kothadia, Sejal [1 ]
Dent, Paul [1 ]
机构：
[1] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e16268
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16268
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [31] Neoadjuvant FOLFIRINOX versus adjuvant gemcitabine in pancreatic cancer.
    Wolfe, Adam R.
    Miller, Eric David
    Abushahin, Laith I.
    Cloyd, Jordan
    Manilchuck, Adrei
    Dillhoff, Mary
    Pardo, Dayssy Alexandra Diaz
    Noonan, Anne M.
    Williams, Terence M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Induction gemcitabine cisplatin followed by chemoradiation in locally advanced nasopharyngeal cancer.
    Usman, Sadaf
    Rasheed, Sara
    Raza, Ali
    Hussain, Raza
    Jamshed, Arif
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Neoadjuvant chemotherapy and concurrent chemoradiation in the treatment of avanced cervical cancer
    Gadducci, A
    Cosio, S
    Cionini, L
    Genazzani, AR
    ANTICANCER RESEARCH, 2001, 21 (05) : 3525 - 3533
  • [34] Phase I study of definitive chemoradiation with gemcitabine and the WEE1 inhibitor AZD1775 in unresectable pancreatic cancer.
    Cuneo, Kyle Clifford
    Morgan, Meredith
    Schipper, Matthew J.
    Maybaum, Jonathan
    Al-Hawary, Mahmoud
    Simeone, Diane M.
    Sahai, Vaibhav
    Zalupski, Mark
    Lawrence, Theodore Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [35] Bladder Preservation by Neoadjuvant Chemotherapy followed by Concurrent Chemoradiotherapy with Gemcitabine in Muscle Invasive Bladder Cancer (MIBC)
    Anandadas, C.
    Thompson, C.
    Sanderson, B.
    Lyons, J.
    Stratford, J.
    Logue, J. P.
    CLINICAL ONCOLOGY, 2013, 25 (04) : E69 - E69
  • [36] STUDY OF NEOADJUVANT CHEMOTHERAPY WITH A CARBOPLATIN AND TAXOL FOLLOWED BY CHEMORADIATION VERSUS CHEMORADIATION FOR LOCALLY ADVANCED CERVICAL CANCER
    Hegazy, Hanady
    Hegazy, Neamat
    Soliman, Maher
    Elsaid, Amr
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A14 - A15
  • [37] Neoadjuvant Chemoradiation With Gemcitabine and S-1 for Patients With Locally Advanced Pancreatic Cancer
    Kurata, M.
    Honda, G.
    Tsuruta, K.
    Kamisawa, T.
    Karasawa, K.
    PANCREAS, 2009, 38 (08) : 1020 - 1020
  • [38] Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer
    Thompson, Catherine
    Joseph, Nuradh
    Sanderson, Benjamin
    Logue, John
    Wylie, James
    Elliott, Tony
    Lyons, Jeanette
    Anandadas, Carmel
    Choudhury, Ananya
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (04): : 732 - 739
  • [39] Postoperative adjuvant gemcitabine plus oxaliplatin (GemOx) chemotherapy followed by chemoradiation in patients with pancreatic carcinoma: A multicenter phase II study
    Mornex, F.
    Andre, T.
    Louvet, C.
    Seitz, J.
    Ychou, M.
    Lledo, G.
    Touboul, E.
    Partensky, C.
    Balosso, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Superiority of extended neoadjuvant chemotherapy with gemcitabine in pancreatic cancer
    Egberts, Jan-Hendrik
    Schniewind, Bodo
    Sipos, Bence
    Hinz, Sebastian
    Kalthoff, Holger
    Tepel, Juergen
    CANCER BIOLOGY & THERAPY, 2007, 6 (08) : 1227 - 1232
12345